Relapse And/or Refractory AML
1 clinical trials · Condition
◉ Watch Relapse And/or Refractory AML
| Record | Firm | Date |
|---|---|---|
| Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT (NCT06686173) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2025-02-01 |
Track Relapse And/or Refractory AML automatically
Every clearance here is in the API, with alerts when new ones post.